Gemalto Awarded Multi-Year Service Contract for New British Passports
Gemalto, the world leader in digital security, today announces it has won an open tender with the Home Office, acting through Her Majesty’s Passport Office (HMPO), for the production of the next generation of British passports and associated services.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180422005018/en/
Current British passport. Credit: istockphoto.
Gemalto, an international security company with substantial operations in the UK, won the contract following a rigorous competitive process which rated each bidder against strict requirements that included security capabilities, processes, technical quality and the value for money for the taxpayer. The contract is for 11.5 years, including 10 years of production and issuance services.
British citizens will soon carry one of the most technically advanced passports in the world thanks to a combination of high-end security features. For the first time, the British passport’s data page (also known as the biographical data page) will be made from polycarbonate instead of paper. This material makes the document extremely secure; any attempt to tamper with it causes visible damage. The material is more durable than paper, preserving the integrity of the document over its lifespan. The digital component of the new British passport will rely on a highly secure Operating System designed to comply with ICAO* standards, developed and secured in-house by Gemalto.
Mark Thomson, Director General for HM Passport Office, said: “I am delighted that we have awarded the contract to design and produce the new blue passport. I look forward to working with Gemalto to continue to deliver a world-class service to British nationals around the world, and keep the UK passport as a global leader of document security.”
Howard Berg, Managing Director of Gemalto UK Ltd, said, “We are delighted to have been selected by Her Majesty’s Passport Office to deliver the new generation of British passports. As a pioneer of cutting edge government document design, we’re confident that the new passports will be the most attractive and most secure ever, as befits the British traveller.”
The passports will be personalised in the UK to ensure all citizens’ personal and biometric data remains in the country. This process will further extend Gemalto’s presence in the UK, where it has operated for the last 25 years and create new jobs, supplementing the 500+ staff which Gemalto already employs in the UK, as well as generating secondary economic benefits in the local communities where Gemalto will be manufacturing the passports. In line with HMPO tender requirements, Gemalto has developed a complete business continuity plan, featuring the multi sourcing of key components and a manufacturing capability distributed over several factories.
Gemalto will be manufacturing the first CarbonNeutral® certified passport. The carbon footprint of the new British passport will be independently measured, validated and reduced to net zero in line with The CarbonNeutral Protocol – the global standard for carbon neutrality.
Frederic Trojani, Executive Vice President of Gemalto Government Business Unit added, “Over the past decade, Gemalto has helped develop some of the world's most secure passports, including landmark projects in Norway, Sweden, USA, Finland and Singapore. We look forward to working with Her Majesty’s Passport Office to deliver one of the most technically advanced passports ever.”
Gemalto has extensive experience in developing secure government documents; its products and solutions are deployed in more than 200 active government programs worldwide including over 40 ePassport programs. It has pioneered secure document techniques, including polycarbonate data pages and a wide portfolio of visual and tactile features to protect citizens’ identities with top results in the various benchmarks organised by the industry. Last year Gemalto acquired Cogent, a leading identity and biometric security company, adding further expertise and scale across the spectrum of biometric solutions, with a particular focus in civil identification, border control and law enforcement.
*ICAO (International Civil Aviation Organization)
Notes to editors
For more information contact:
Gemalto Press Office at Brands2Life
email@example.com / 0207 592 1200
Gemalto (Euronext NL0000400653 GTO) is the global leader in digital security, with 2017 annual revenues of €3 billion and customers in over 180 countries. We bring trust to an increasingly connected world.
From secure software to biometrics and encryption, our technologies and services enable businesses and governments to authenticate identities and protect data so they stay safe and enable services in personal devices, connected objects, the cloud and in between.
Gemalto’s solutions are at the heart of modern life, from payment to enterprise security and the internet of things. We authenticate people, transactions and objects, encrypt data and create value for software – enabling our clients to deliver secure digital services for billions of individuals and things.
Our 15,000 employees operate out of 114 offices, 40 personalization and data centers, and 35 research and software development centers located in 47 countries.
Gemalto Press Office at Brands2Life
0207 592 1200
Gemalto media contacts:
Tauri Cox, +1 512 257 3916
Sophie Dombres, +33 4 42 36 57 38
Europe Middle East & Africa
Jaslin Huang, +65 6317 3005
Enriqueta Sedano, +52 5521221422
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of Endari™ (L-Glutamine Oral Powder) in Sickle Cell Disease19.7.2018 00:45 | Tiedote
VIEW E-MEDIA KIT – Emmaus Life Sciences, Inc. (Emmaus) announced today that the New England Journal of Medicine (NEJM) has published the results of its 48-week phase 3 clinical trial of Endari™ (L-glutamine oral powder) which supported the FDA approval in July 2017 to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older. The article reports results that showed significantly fewer sickle cell crises in those receiving Endari compared to placebo by 25 percent; p=0.005 (median 3 vs. median 4) and significantly fewer hospitalizations by 33 percent; p=0.005 (median 2 vs. median 3). Additional findings showed lower cumulative days in hospital of 41 percent; p=0.02 (median 6.5 days vs. median 11 days) and a lower incidence of acute chest syndrome (ACS) by more than 60 percent; p=0.003 (13 of 152 patients [8.6%] had at least 1 ACS compared with 18 of 78 in the placebo group [23.1%]). The most common adverse reactions, occurring in great
Tigo Releases State-of-the-art Wireless Technology – Mesh – as the New Solar Communication Architecture for the TS4 Platform18.7.2018 22:41 | Tiedote
Tigo®, pioneer of the smart modular Flex MLPE platform, today announced the release of its new Mesh communication architecture. This state-of-the-art wireless technology directly translates to customer benefits – including simplifying the solar design process and accelerating the commissioning steps. The complete Tigo solution uses a simple yet powerful data collection technology that covers the widest ranges of residential & commercial installations at the lowest cost. With Mesh and the recently announced Tigo Access Point (TAP), customers eliminate the need to address any roof obstruction or orientation constraint. To learn more about Mesh and TAP, register for Tigo’s free, online webinar “The Future of Solar is Wireless” on Wednesday July 25th, 2018 at 10am PDT. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180718005827/en/ Mesh is Tigo's proprietary software that allows each TS4 unit to act as a repeater, extending the
ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 20:21 | Tiedote
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li
Xilam: H1 2018 Revenue: +50%18.7.2018 19:00 | Tiedote
Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t
Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 15:38 | Tiedote
The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign
Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 15:05 | Tiedote
Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme